Cite
Control of the heparosan N-deacetylation leads to an improved bioengineered heparin.
MLA
Wang, Zhenyu, et al. “Control of the Heparosan N-Deacetylation Leads to an Improved Bioengineered Heparin.” Applied Microbiology & Biotechnology, vol. 91, no. 1, July 2011, pp. 91–99. EBSCOhost, https://doi.org/10.1007/s00253-011-3231-5.
APA
Wang, Z., Yang, B., Zhang, Z., Ly, M., Takieddin, M., Mousa, S., Liu, J., Dordick, J., & Linhardt, R. (2011). Control of the heparosan N-deacetylation leads to an improved bioengineered heparin. Applied Microbiology & Biotechnology, 91(1), 91–99. https://doi.org/10.1007/s00253-011-3231-5
Chicago
Wang, Zhenyu, Bo Yang, Zhenqing Zhang, Mellisa Ly, Majde Takieddin, Shaker Mousa, Jian Liu, Jonathan Dordick, and Robert Linhardt. 2011. “Control of the Heparosan N-Deacetylation Leads to an Improved Bioengineered Heparin.” Applied Microbiology & Biotechnology 91 (1): 91–99. doi:10.1007/s00253-011-3231-5.